|
| Tuesday, 8 November 2022, 08:56 HKT/SGT | |
| |
|
|
|
香港, 2022年11月8日 - (亚太商讯) - 中国领先的结构性心脏病介入器械供应商心泰医疗（2291.HK)今日在港交所挂牌上市。该股昨日于富途暗盘交易中最高涨5.15%至30.65港元，最终收涨2.23%报29.8港元；该股IPO发售价格为29.15港元。
公司是中国最大的先天性心脏病封堵器产品及相关手术配套产品制造商，按2021年于中国销售确认的收入计，公司的市场份额为38.0%。此次上市发售2245.5万股，其中香港发售224.6万股，国际发售2020.9万股，每手1000股，香港公开发售获2.11倍认购，净筹5.673亿港元，当中约50.7%将用于为公司未来五年内的研发活动提供资金；约24.3%将用于公司未来五年内的销售及营销活动。
财务方面，2019-2021年，公司的营业收入分别为人民币1.16亿元、1.48亿元、2.23亿元，复合年增长率为38.25%；同期综合毛利率分别为88.3%、89.8%、88.8%。
话题 Press release summary
部门 制药及生物技术, 健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network
|
|
|
|
|
|
|
|
Latest Press Releases
AAC Technologies CFO Guo Dan: Accelerating Expansion into AI Blue Ocean for a New Revenue Milestone in 2026
Mar 26, 2026 14:43 HKT/SGT
|
|
|
Nissin Foods Announces 2025 Annual Results
Mar 26, 2026 12:21 HKT/SGT
|
|
|
CALB (03931.HK) Achieves Mass Production Roll-off of Pioneering Aviation Battery System, Powered by Advanced R46 Cylindrical Batteries
Mar 26, 2026 10:56 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 26, 2026 10:49 HKT/SGT
|
|
|
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
Thursday, March 26, 2026 10:21:00 AM
|
|
|
MHI-AP Awarded Boiler Retrofit Contract for Waste-to-Energy Facility in Singapore
Thursday, March 26, 2026 10:07:00 AM
|
|
|
TransNusa Becomes First Indonesian Airline to Receive Additional Flight Frequencies from World-Renowned Changi Airport in 2026
Mar 26, 2026 09:30 HKT/SGT
|
|
|
Formerra Announces Transportation Surcharge to Address Ongoing Freight and Logistics Market Pressures
Mar 26, 2026 04:00 HKT/SGT
|
|
|
Aleen Inc. Introduces Biomarker Data Layer in Personal Wellness Account
Mar 25, 2026 23:28 HKT/SGT
|
|
|
Hengrui Pharma Announces Strong 2025 Annual Results
Mar 25, 2026 23:15 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
